Jeffrey Stein - Mar 11, 2024 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
President & CEO, Director
Signature
/s/ Shane Ward, Attorney-in-Fact
Stock symbol
CDTX
Transactions as of
Mar 11, 2024
Transactions value $
-$39,117
Form type
4
Date filed
3/12/2024, 09:48 PM
Previous filing
Sep 21, 2023
Next filing
Mar 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Tax liability -$39.1K -56.7K -4.68% $0.69 1.15M Mar 11, 2024 Direct F1, F2
holding CDTX Common Stock 332K Mar 11, 2024 By trust
holding CDTX Common Stock 42K Mar 11, 2024 By son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for taxes on RSU vesting.
F2 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on November 20, 2023.